Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05253352 · ClinicalTrials.gov registry record
Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway
A clinical trial of Lymphatic System, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- 142
- Enrollment target
- 1
- Study location
NCT05253352 is a study of Lymphatic System that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 142 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05253352, a study of Lymphatic System, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- 142 participants
- Enrollment target
- 1
- Study location
Study Summary
Using indocyanine green (ICG) lymphography and lymphoscintigraphy with SPECT/CT imaging, the aim is to evaluate the anatomy of the lymphatic system pathway in two separate populations: healthy female volunteers and women with a history of breast cancer who did not develop lymphedema.
Conditions Studied
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05253352
The ClinicalTrials.gov registry entry for NCT05253352 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphatic System appearing as the primary indexed condition, and to 0 interventions.
NCT05253352 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05253352 about?
NCT05253352 is a clinical study titled "Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway". Using indocyanine green (ICG) lymphography and lymphoscintigraphy with SPECT/CT imaging, the aim is to evaluate the anatomy of the lymphatic system pathway in two separate populations: healthy female volunteers and women with a history of breast cancer who did not develop lymphedema.
What is the current status of trial NCT05253352?
This trial is currently recruiting. The enrollment target is 142 participants. The study started on 2022-04-01. Estimated completion is 2026-12.
What conditions does trial NCT05253352 study?
This clinical trial studies the following conditions: Lymphatic System.
Who is sponsoring clinical trial NCT05253352?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05253352 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.